2023 Annual Meeting | C188 - Critical Care Consultations for Neurohospitalists

Date Thursday 04/27/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jana Wold, MD

Topic(s) Neuro Trauma and Critical Care

Learning Objectives Participants should be able to employ methods to recognize patients at risk for delirium and enact treatments for in-hospital delirium; recognize the neurologic side effects of emerging cancer therapies and how to mitigate the risk of such side effects; and discuss updates to the prognostication of neurologic outcomes in cardiac arrest patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:05 AM - 07:40 AM EST	Speaker	The Dark Side of Emerging Cancer Therapies Alexandra Muccilli, MD
07:40 AM - 08:15 AM EST	Speaker	Delirium Management for the Neurohospitalist Sara LaHue, MD
08:15 AM - 08:50 AM EST	Speaker	Updates in Prognostication and Management of Anoxic Brain Injury Jana Wold, MD

Faculty Disclosures
Jana Wold, MD	Dr. Wold has nothing to disclose.
Sara LaHue, MD	The institution of Dr. LaHue has received research support from National Institute on Aging . The institution of Dr. LaHue has received research support from Larry L. Hillblom Foundation . The institution of Dr. LaHue has received research support from UCSF Claude D. Pepper Older Americans Independence Center . The institution of Dr. LaHue has received research support from UCSF Bakar Aging Research Institute. The institution of Dr. LaHue has received research support from Doris Duke Foundation . Dr. LaHue has received publishing royalties from a publication relating to health care.
Alexandra Muccilli, MD	Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Muccilli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.